Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)
Launched by WYETH IS NOW A WHOLLY OWNED SUBSIDIARY OF PFIZER · Sep 30, 2005
Trial Information
Current as of May 23, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of complicated intra-abdominal infection that requires surgery within 24 hours.
- • Fever plus other symptoms such as nausea, vomiting, abdominal pain.
- Exclusion Criteria:
- • Cancer
- • Medicines that suppress the immune system
- • Dialysis
About Wyeth Is Now A Wholly Owned Subsidiary Of Pfizer
Wyeth, now a wholly owned subsidiary of Pfizer, is a global biopharmaceutical company dedicated to advancing healthcare through innovative research and development. With a strong legacy in the pharmaceutical industry, Wyeth focuses on discovering and delivering medicines that address significant medical needs across various therapeutic areas, including vaccines, biologics, and specialty pharmaceuticals. Leveraging Pfizer's extensive resources and expertise, Wyeth continues to drive scientific advancement and improve patient outcomes worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Freiburg, , Germany
Genova, , Italy
Vicenza, , Italy
Madrid, , Spain
Bern, , Switzerland
Shanghai, , China
Barcelona, , Spain
Madrid, , Spain
Tainan, , Taiwan
Udine, , Italy
Pierre Benite, , France
Lahti, , Finland
Pavia, , Italy
Barcelona, , Spain
Muenster, , Germany
Bochum, , Germany
Taipei, , Taiwan
Odense, , Denmark
Leipzig, , Germany
Pietermaritzburg, , South Africa
Athens, , Greece
Birmingham, , United Kingdom
Heidelberg, , Germany
Coimbra, , Portugal
Ankara, , Turkey
Frankfurt, , Germany
Lucknow, , India
Brescia, , Italy
Almada, , Portugal
Pokfulam, , Hong Kong
Parkville, , Australia
Geneva, , Switzerland
Zurich, , Switzerland
Riyadh, , Saudi Arabia
Bilbao, , Spain
Nambour, Queensland, Australia
Cairns, , Australia
Seinajoki, , Finland
Tampere, , Finland
Marseille, , France
Nimes, , France
Saint Denis, , France
Luebeck, , Germany
Tuebingen, , Germany
Thessaloniki, , Greece
New Territories, , Hong Kong
Hyderabad, Andhra, India
Bhopal, , India
Mumbai, , India
New Delhi, , India
Rome, , Italy
Manila, , Philippines
Quezon City, , Philippines
Porto, , Portugal
Bellville, , South Africa
Kuilsriver, , South Africa
Parow, , South Africa
Pretoria, , South Africa
Bilbao, , Spain
Murcia, , Spain
Lugano, , Switzerland
Changhua, , Taiwan
Taichung, , Taiwan
Tao Yuan, , Taiwan
Istanbul, , Turkey
Stockport, Cheshire, United Kingdom
Wigan, , United Kingdom
Patients applied
Trial Officials
Medical Monitor
Study Director
Wyeth is now a wholly owned subsidiary of Pfizer
Trial Manager
Principal Investigator
For Australia, China, Hong Kong, medinfo@wyeth.com
Trial Manager
Principal Investigator
For Taiwan, medinfo@wyeth.com
Trial Manager
Principal Investigator
For Denmark, Finland, MedInfoNord@wyeth.com
Trial Manager
Principal Investigator
For Germany, MedinfoDEU@wyeth.com
Trial Manager
Principal Investigator
For South Africa, ZAFinfo@wyeth.com
Trial Manager
Principal Investigator
For Italy, Greece, decresg@wyeth.com
Trial Manager
Principal Investigator
For UK, ukmedinfo@wyeth.com
Trial Manager
Principal Investigator
For Switzerland, med@wyeth.com
Trial Manager
Principal Investigator
For France, infomedfrance@wyeth.com
Trial Manager
Principal Investigator
For Spain, infomed@wyeth.com
Trial Manager
Principal Investigator
For Turkey, Erisc@wyeth.com
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials